thymopentin has been researched along with Adenocarcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gisselsson, D; Hansen, GB; Höglund, M; Mitelman, F | 1 |
| Fowler, WC; Gerçel-Taylor, C; Taylor, DD; Weese, JL | 1 |
| Ameglio, F; Di Lauro, L; Gandolfo, G; Gionfra, T; Lopez, M; Paoletti, G | 1 |
| Coghetto, F; De Angeli, S; Fantin, P; Gava, A; Marazzato, G; Moro, L; Patrese, P | 1 |
1 trial(s) available for thymopentin and Adenocarcinoma
| Article | Year |
|---|---|
Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: preliminary results.
Topics: Adenocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Interleukin-2; Leucovorin; Liver Neoplasms; Male; Middle Aged; Thymopentin | 1991 |
3 other study(ies) available for thymopentin and Adenocarcinoma
| Article | Year |
|---|---|
Statistical dissection of cytogenetic patterns in lung cancer reveals multiple modes of karyotypic evolution independent of histological classification.
Topics: Adenocarcinoma; Aneuploidy; Biological Evolution; Carcinoma, Squamous Cell; Chromosome Aberrations; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 7; Cluster Analysis; Databases, Factual; Humans; Karyotyping; Lung Neoplasms; Thymopentin; Time Factors | 2004 |
Enhancement of antitumor effects of combined chemoimmunotherapy.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; Chemotherapy, Adjuvant; Disease Models, Animal; Fluorouracil; Immunotherapy; Levamisole; Lung Neoplasms; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Thymopentin | 1993 |
[Effects of radiotherapy on lymphocyte populations in lung cancer].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; B-Lymphocytes; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphocytes, Null; Male; Middle Aged; Peptide Fragments; Pneumonectomy; Radioisotope Teletherapy; T-Lymphocytes; Thymopentin; Thymopoietins; Time Factors | 1988 |